The INFLUENCE of rare Genetic variation in SLC30A8 on diabetes incidence and beta-cell function. J Clin Endocrinol Metab. PMID: 24471563.
Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process. Curr Drug Metab. PMID: 24479687.
Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell lines. Pharmacogenomics. PMID: 24444404.
Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene. Ann Rheum Dis. PMID: 24448344.
Personal DNA donation to energize genomic medicine. Clin Pharmacol Ther. PMID: 24448457.
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia. Blood. PMID: 24449211.
Identifying druggable targets by protein microenvironments matching: application to transcription factors. CPT Pharmacometrics Syst Pharmacol. PMID: 24452614.
Correction: Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients. PLoS One. PMID: 24454624.
Patients' Understanding of How Genotype Variation Affects Benefits of Tamoxifen Therapy for Breast Cancer. Public Health Genomics.PMID: 24457521.
Genetic Influence on Exercise-Induced Changes in Physical Function among Mobility-Limited Older Adults. Physiol Genomics. PMID: 24423970.
Validation of PhenX measures in the personalized medicine research project for use in gene/environment studies. BMC Med Genomics. PMID: 24423110.
Identification of BACH2 and RAD51B as rheumatoid arthritis susceptibility loci in a meta-analysis of genome-wide data. Arthritis Rheum. PMID: 24022229.
Common variants in Mendelian kidney disease genes and their association with renal function. J Am Soc Nephrol. PMID: 24029420.
Identifying phenotypic signatures of neuropsychiatric disorders from electronic medical records. J Am Med Inform Assoc. PMID: 23956017.
Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet Genomics. PMID: 23838604.
Challenges in interpreting the evidence for genetic predictors of ototoxicity. Clin Pharmacol Ther. PMID: 24241639.
Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther. PMID: 23988873.
Genetic and pharmacokinetic determinants of response to transdermal nicotine in white, black, and Asian nonsmokers. Clin Pharmacol Ther. PMID: 23933970.
PharmGKB summary: methylene blue pathway. Pharmacogenet Genomics. PMID: 23913015.
Exome resequencing identifies potential tumor-suppressor genes that predispose to colorectal cancer. Hum Mutat. PMID: 23585368.
Genetic mechanisms of atrial fibrillation: impact on response to treatment. Nat Rev Cardiol. PMID: 23591267.
Special Section on Pharmacogenomics: recent advances and future directions. J Hum Genet. PMID: 23797326.
Genomic medicine: a decade of successes, challenges, and opportunities. Sci Transl Med. PMID: 23761042.
Pharmacogenomics of anti-platelet therapy: how much evidence is enough for clinical implementation? J Hum Genet. PMID: 23697979.
Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia. J Hum Genet. PMID: 23677058.
Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity. J Hum Genet. PMID: 23677053.
VKORC1 Asp36Tyr geographic distribution and its impact on warfarin dose requirements in Egyptians. Thromb Haemost. PMID: 23571513.
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer. Breast Cancer Res Treat. PMID: 23546553.
Genetic risk factors for BMI and obesity in an ethnically diverse population: results from the population architecture using genomics and epidemiology (PAGE) study. Obesity (Silver Spring). PMID: 23712987.